Latest Gilead Sciences Inc. Stories
GENEVA, September 25, 2014 /PRNewswire/ -- MPP signs sub-licences with six generic manufacturers for the development of Phase III
PITTSBURGH and HYDERABAD, India, Sept. 15, 2014 /PRNewswire/ -- Mylan Inc.
A new combination therapy could cut treatment time for hepatitis C to just four weeks, but quicker recovery comes with a steep price, as the new medication is said to cost roughly $1,000 per pill.
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
PHOENIX, March 3, 2014 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released insider trading reports for U.S.
PHOENIX, Feb. 24, 2014 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released insider trading reports for U.S.
PITTSBURGH and MUMBAI, India, Jan. 31, 2014 /PRNewswire/ -- Mylan Inc.
- totally perplexed and mixed up.